We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Transfusion needs after CD19 CAR T‐cells for large B‐cell lymphoma: predictive factors and impact on outcome. A DESCAR‐T study.
- Authors
Vic, S.; Thibert, J.; Bachy, E.; Cartron, G.; Gastinne, T.; Morschhauser, F.; Le Bras, F.; Bouabdallah, K.; Despas, F.; Bay, J.; Rubio, M.; Mohty, M.; Casasnovas, O.; Choquet, S.; Castilla‐Llorente, C.; Guidez, S.; Loschi, M.; Guffroy, B.; Carras, S.; La Rochelle, L. Drieu
- Abstract
Transfusion needs may impact patients' quality of life and CAR T-cells efficacy through transfusion-related immunomodulation. Transfusion needs after CD19 CAR T-cells for large B-cell lymphoma: predictive factors and impact on outcome. B Introduction: b Patients undergoing CAR T-cell therapy may experience severe cytopenias due to lymphodepleting chemotherapy and/or CAR T-cells.
- Subjects
T cells; CD19 antigen; ERYTHROCYTES; LYMPHOMAS; CYTOKINE release syndrome
- Publication
Hematological Oncology, 2023, Vol 41, p534
- ISSN
0278-0232
- Publication type
Article
- DOI
10.1002/hon.3164_397